Next-generation sequencing in oncology in the era of precision medicine

JAMA Oncology

Volumn 2, Issue 1, 2016, Pages 13-14

  Blumenthal, Gideon M ^a   Mansfield, Elizabeth ^a   Pazdur, Richard ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ANIMAL; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; MOLECULARLY TARGETED THERAPY; NEOPLASMS; ONCOLOGY; PATHOLOGY; PERSONALIZED MEDICINE; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES;

ANIMALS; BIOMARKERS, TUMOR; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MEDICAL ONCOLOGY; MOLECULAR TARGETED THERAPY; NEOPLASMS; PHENOTYPE; PRECISION MEDICINE; PREDICTIVE VALUE OF TESTS;

EID: 84973469444     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2015.4503     Document Type: Short Survey

References (7)

1. US Food and Drug Administration. New drugs at FDA: CDER's new molecular entities and new therapeutic biological products. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm20025676.htm. Updated April 14, 2015. Accessed September 15, 2015.
2. US Food and Drug Administration. List of cleared or approved companion diagnostic devices (in vitro and imaging tools). http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm301431.htm. Updated August 13, 2015. Accessed September 15, 2015.
3. Lindeman NI, Cagle PT, Beasley MB, et al; College of American Pathologists International Association for the Study of Lung Cancer and Association for Molecular Pathology. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Mol Diagn. 2013;15(4):415-453.
4. Collins FS, Hamburg MA. First FDA authorization for next-generation sequencer. N Engl J Med. 2013;369(25):2369-2371.
5. Litwack ED, Mansfield E, Shuren J. The FDA and genetic testing. N Engl J Med. 2015;372(23):2273-2274.
6. White House Office of the Press Secretary. Fact sheet: President Obama's precision medicine initiative [press release]. https://www.whitehouse.gov/the-press-office/2015/01/30/fact-sheet-president-obama-s-precision-medicine-initiative. January 30, 2015. Accessed September 15, 2015.
7. Rehm HL, Berg JS, Brooks LD, et al; ClinGen. ClinGen: the Clinical Genome Resource. N Engl J Med. 2015;372(23):2235-2242.